Last updated on August 2019

A Study to Evaluate the Efficacy Safety Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera

Brief description of study

This is an open-label, single-arm, study of idasanutlin monotherapy in participants with hydroxyurea (HU)-resistant/intolerant Polycythemia vera (PV).

Clinical Study Identifier: NCT03287245

Find a site near you

Start Over

Cleveland Clinic Cancer Center

Independence, OH United States
  Connect »